Home/Filings/4/0001437749-22-012433
4//SEC Filing

Freiman Paul E. 4

Accession 0001437749-22-012433

CIK 0001389545other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 8:31 PM ET

Size

5.0 KB

Accession

0001437749-22-012433

Insider Transaction Report

Form 4
Period: 2022-05-11
Transactions
  • Award

    Restricted Stock Units

    2022-05-11+30,00030,000 total
    Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001410074

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 8:31 PM ET
Size
5.0 KB